Drugs / JNJ-17166864
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00604123 | Jan → Feb 2008 | allergic rhinitis | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-17166864 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00604123 ↗ |
| Modality | Small molecule | — CHEMBL397647 ↗ |
| Route | Intranasal | “Intranasal JNJ-17166864” NCT00604123 ↗ |